cjc-1295 ipamorelin anti-aging benefits igf-1 levels studies CJC 1295, and Retatrutide: UK Safety and Legal Guide – Bolt Pharmacy Research peptide drugs (e.g., CJC-1295,

E-selection, endothelial selectin

Psychopharmacology bulletin

Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy

This dual action appears to amplify the overall GH, such as improved body composition, lipid profile, insulin sensitivity, and overall metabolic function in laboratory test models

doi: 10.3389/fimmu.2025.1714608 Received 14 October 2025 Revised 24 November 2025 Accepted 08 December 2025 Published 07 January 2026 Volume 16 - 2025 Edited by Umadevi S